Jupiter Life Line Hospitals (JLHL) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
19 Dec, 2025Executive summary
Celebrated two years since listing, with business growth aligning with pre-IPO plans and ongoing expansion in Western India, including new hospitals in Dombivli, South Pune, and Mira Road.
All existing hospitals performed as expected, with Pune nearing maturity and Indore showing improved growth post-expansion.
Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, were approved by the Board and reviewed by joint statutory auditors, who issued unmodified reports.
The group is primarily engaged in healthcare services in India, with no other reportable segments as per Ind AS 108.
Focus remains on operational strengths, clinical excellence, and patient-centric growth in Western India.
Financial highlights
Q2 FY26 operating income was INR 374.4 crores, up 11.7% year-on-year; EBITDA reached INR 85.4 crores, up 9.3% year-on-year, with a margin of 22.8%.
Q2 PAT was INR 57.4 crores, up 11% year-on-year, with a margin of 15.3%.
H1 FY26 operating income was INR 727.4 crores, up 14.9% year-on-year; EBITDA was INR 163.8 crores, up 13.7% year-on-year, with a margin of 22.5%.
Consolidated revenue from operations for Q2 FY26 was ₹3,936.29 million, up from ₹3,350.49 million in Q2 FY25; half-year revenue was ₹7,465.82 million, up from ₹6,329.34 million year-over-year.
Consolidated net profit for Q2 FY26 was ₹574.77 million, compared to ₹518.36 million in Q2 FY25; half-year net profit was ₹1,014.22 million, up from ₹962.56 million year-over-year.
Outlook and guidance
New hospitals are expected to be EBITDA negative in their first year and break even in the second year, leading to temporary margin dilution at the consolidated level.
Dombivli hospital (500 beds) expected to be operational in Q1FY27; South Pune (500 beds) in CY28; Mira Bhayandar (400 beds) in CY29.
Total bed capacity projected to increase from 1,061 to approximately 2,500 with upcoming projects.
The company continues to focus on healthcare services as its core business, with no significant changes in segment reporting or business model.
Dombivli Hospital is expected to reach EBITDA break-even by the second year, typically at 40-45% occupancy.
Latest events from Jupiter Life Line Hospitals
- Q1 FY25 saw strong revenue, profit, digital accreditation, and capacity expansion.JLHL
Q1 24/253 Feb 2026 - Strong revenue and profit growth, with major expansion and capital investment underway.JLHL
Q2 24/253 Feb 2026 - Q3 FY26 revenue up 9.8% YoY, but PAT fell on labor code; major hospital expansion underway.JLHL
Q3 25/262 Feb 2026 - FY25 saw strong growth, a recommended dividend, and major expansion and restructuring.JLHL
Q4 24/2519 Dec 2025 - Q1 FY26 revenue and EBITDA rose, but PAT declined on higher costs; volumes and ARPOB up.JLHL
Q1 25/2619 Dec 2025 - Strong growth and expansion, with new hospitals funded by internal accruals and no new debt.JLHL
Q3 24/2519 Dec 2025